RenovoRx, Inc.
RNXT· Nasdaq
Released May 12, 2023, after the close
10-Q filed May 12, 2023, 42 days after period end · 0001493152-23-016648
| Metric | Q1 2023 | Q1 2022 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|
| Net Income | -$3.26M | -$3.00M | -$1.15M | -$1.05M |
| EPS Diluted | -$0.36 | — | — | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
RenovoRx, Inc. · CIK 1574094 · Engraved from SEC EDGAR